58Q-20605-72288
2 vaccinations
4 coded responses
17 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 100 / NY
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Registered in v-safe
- 2021-04-15
-
2021-04-21
Dose 2 — Pfizer-BioNTech
-
2021-04-21
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: Good · Site: PainFree text: Miscarriage on April 18 between first and second doses.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-28
- 2021-06-02
-
2021-07-21
Survey response — 3 months, dose 2MedDRA: Anxiety, Dizziness — Feeling: GoodFree text: Anxiety attacks (feeling faint)MedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-26
-
2022-04-21
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Another chemical pregnancy and another missed miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-04-21
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-21 | Unsuccessful | |
| 2022-04-21 | Unsuccessful |
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Miscarriage on April 18 between first and second doses.
Release 9 — 3 months, dose 2
Symptoms: Anxiety attacks (feeling faint)
Release 10 — 6 months, dose 2
Symptoms: Miscarriage
Release 11 — 12 months, dose 2
Symptoms: Another chemical pregnancy and another missed miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release